Stocks Health care BTMD
NASDAQ · Health carebiote Corp. (BTMD)
biote Corp. brought in $183.5M of revenue over the twelve months to June 30, 2026, down 7.8% from a year earlier. Net income was $5.9M, a net margin of 3.2%. Operating cash flow minus capital spending left $30.2M of free cash flow in fiscal 2025. At June 30, 2026 it held $11.2M in cash against $125M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
What biote Corp. does
biote Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker BTMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $192.2M | $27M | $0.74 | $30.2M |
| 2024 | $197.2M | $3.2M | $0.09 | $38.8M |
| 2023 | $185.4M | $3.3M | $0.13 | $26.5M |
| 2022 | $165M | -$969K | -$0.12 | -$9.5M |
| 2021 | $139.4M | $11.1M | n/a | $32.3M |
Latest SEC filings
What biote Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 18, 2026Passive stake changed SCHEDULE 13G/A
- September 1, 2026Passive stake changed SCHEDULE 13G/A
- August 28, 2026Passive stake (5% or more) SCHEDULE 13G
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026
- August 5, 2026
- July 27, 2026Passive stake changed SCHEDULE 13G/A
- June 17, 2026
- June 2, 2026
- May 18, 2026
- May 13, 2026Passive stake changed SCHEDULE 13G/A
Questions about BTMD
What does biote Corp. do?
biote Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker BTMD.
Is biote Corp. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $5.9M on revenue of $183.5M, a net margin of 3.2%.
How much revenue does biote Corp. make?
Over the twelve months to June 30, 2026 biote Corp. reported revenue of $183.5M. That is 7.8% less than a year earlier.
When did biote Corp. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from September 18, 2026.
Similar companies
Follow BTMD
Get an email when biote Corp. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BTMD: get an email when it filesWhere the numbers come from
Financial figures are the values biote Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.